David Linetsky $PHR SEC Form 4 Insider Trading

David Linetsky has filed a total of 53 insider trades in $PHR since 2021. Their most recent trade was a sale of 300 shares, made on Feb 07, 2025. Their largest trade was a sale of 30,659 shares, made on Jan 17, 2024. We estimate that they now own 238,602 shares of $PHR, worth an estimated $6.7 million.

Insider Trading at $PHR

There have been a total of 263 insider trades reported at $PHR since 2021, with 0 shares purchased and 1.1 million shares sold. The most active insider traders in $PHR stock have been David Linetsky, Evan Roberts, and Allison C Hoffman. The most recent trade was a sale of 300 shares reported by David Linetsky (SVP, Life Sciences), made on Feb 07, 2025.

$PHR Executives and Stock Owners with Insider Trades

• David Linetsky, SVP, Life Sciences

• Evan Roberts, Chief Operating Officer

• Allison C Hoffman, General Counsel & Secretary

• Amy Beth Vanduyn, SVP, Human Resources

• Chaim Indig, Chief Executive Officer

• Balaji Gandhi, Chief Financial Officer

• Michael J. Davidoff, SVP, Payer Business

• Janet Gunzburg, Principal Accounting Officer

• Yvonne Hui, Principal Accounting Officer

• Randy Rasmussen, Chief Financial Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.